{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:39:19Z","timestamp":1784043559066,"version":"3.55.0"},"reference-count":308,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>Cancer cachexia, a multifactorial metabolic syndrome developed during malignant tumor growth, is characterized by an accelerated loss of body weight accompanied by the depletion of skeletal muscle mass. This debilitating condition is associated with muscle degradation, impaired immune function, reduced functional capacity, compromised quality of life, and diminished survival in cancer patients. Despite the lack of the known capability of fully reversing or ameliorating this condition, ongoing research is shedding light on promising preclinical approaches that target the disrupted mechanisms in the pathophysiology of cancer cachexia. This comprehensive review delves into critical aspects of cancer cachexia, including its underlying pathophysiological mechanisms, preclinical models for studying the progression of cancer cachexia, methods for clinical assessment, relevant biomarkers, and potential therapeutic strategies. These discussions collectively aim to contribute to the evolving foundation for effective, multifaceted counteractive strategies against this challenging condition.<\/jats:p>","DOI":"10.3390\/metabo13091024","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T21:26:32Z","timestamp":1695245192000},"page":"1024","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cancer Cachexia: Underlying Mechanisms and Potential Therapeutic Interventions"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1215-9056","authenticated-orcid":false,"given":"Dean","family":"Directo","sequence":"first","affiliation":[{"name":"Department of Kinesiology, New Mexico State University, Las Cruces, NM 88003, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0306-3854","authenticated-orcid":false,"given":"Sang-Rok","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Kinesiology, New Mexico State University, Las Cruces, NM 88003, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: Understanding the molecular basis","volume":"14","author":"Busquets","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.bbadis.2011.08.010","article-title":"Gut barrier dysfunction in the ApcMin\/+ mouse model of colon cancer cachexia","volume":"1812","author":"Puppa","year":"2011","journal-title":"Biochim. Biophys. Acta-Mol. Basis Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev-med-061509-131248","article-title":"Muscle wasting in cancer cachexia: Clinical implications, diagnosis, and emerging treatment strategies","volume":"62","author":"Dodson","year":"2011","journal-title":"Annu. Rev. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.clnu.2007.03.011","article-title":"Pathophysiology of cancer cachexia: Much more than host-tumour interaction?","volume":"26","author":"Skipworth","year":"2007","journal-title":"Clin. Nutr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group","volume":"69","author":"Dewys","year":"1980","journal-title":"Am. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1038\/oncsis.2016.3","article-title":"Understanding cachexia as a cancer metabolism syndrome","volume":"5","author":"Porporato","year":"2016","journal-title":"Oncogenesis"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00432-019-02883-6","article-title":"The application of Apc","volume":"145","author":"Ren","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"White, J.P., Baynes, J.W., Welle, S.L., Kostek, M.C., Matesic, L.E., Sato, S., and Carson, J.A. (2011). The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min\/+) mouse. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0024650"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1242\/bio.20136544","article-title":"Characterization of the male ApcMin\/+ mouse as a hypogonadism model related to cancer cachexia","volume":"2","author":"White","year":"2013","journal-title":"Biol. Open"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1152\/japplphysiol.00897.2017","article-title":"Skeletal muscle function during the progression of cancer cachexia in the male Apc","volume":"124","author":"VanderVeen","year":"2018","journal-title":"J. Appl. Physiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1152\/japplphysiol.00442.2010","article-title":"Activity level, apoptosis, and development of cachexia in Apc(Min\/+) mice","volume":"109","author":"Baltgalvis","year":"2010","journal-title":"J. Appl. Physiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/0959-8049(95)00181-H","article-title":"ApcMin: A mouse model for intestinal and mammary tumorigenesis","volume":"31","author":"Moser","year":"1995","journal-title":"Eur. J. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1038\/s41598-020-59899-z","article-title":"APC controls Wnt-induced \u03b2-catenin destruction complex recruitment in human colonocytes","volume":"10","author":"Parker","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Aulino, P., Berardi, E., Cardillo, V.M., Rizzuto, E., Perniconi, B., Ramina, C., Padula, F., Spugnini, E.P., Baldi, A., and Faiola, F. (2010). Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse. BMC Cancer, 10.","DOI":"10.1186\/1471-2407-10-363"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3389\/fphys.2016.00679","article-title":"Differential bone loss in mouse models of colon cancer cachexia","volume":"7","author":"Bonetto","year":"2017","journal-title":"Front. Physiol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Kasprzak, A. (2021). The Role of Tumor Microenvironment Cells in Colorectal Cancer (CRC) Cachexia. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041565"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.freeradbiomed.2015.12.019","article-title":"Antioxidant supplementation accelerates cachexia development by promoting tumor growth in C26 tumor-bearing mice","volume":"91","author":"Assi","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/SPC.0000000000000233","article-title":"Animal models for cancer cachexia","volume":"10","author":"Costelli","year":"2016","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.semcdb.2015.09.002","article-title":"Experimental cancer cachexia: Evolving strategies for getting closer to the human scenario","volume":"54","author":"Penna","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s13539-014-0141-2","article-title":"Modeling human cancer cachexia in colon 26 tumor-bearing adult mice","volume":"5","author":"Talbert","year":"2014","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1158\/0008-5472.CAN-10-3145","article-title":"Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner","volume":"71","author":"Cosper","year":"2011","journal-title":"Cancer Res."},{"key":"ref_23","first-page":"2442","article-title":"Characterization of two highly metastatic variants of Lewis lung carcinoma with different organ specificities","volume":"46","author":"Brodt","year":"1986","journal-title":"Cancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.21873\/anticanres.13280","article-title":"Time-restricted Feeding Attenuates High-fat Diet-enhanced Spontaneous Metastasis of Lewis Lung Carcinoma in Mice","volume":"39","author":"Yan","year":"2019","journal-title":"Anticancer. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1111\/j.1349-7006.2007.00633.x","article-title":"Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis","volume":"98","author":"Kimura","year":"2007","journal-title":"Cancer Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/jcsm.13211","article-title":"EXT418, a novel long-acting ghrelin, mitigates Lewis lung carcinoma induced cachexia in mice","volume":"14","author":"Kerr","year":"2023","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/jcsm.12864","article-title":"Development of ovarian tumour causes significant loss of muscle and adipose tissue: A novel mouse model for cancer cachexia study","volume":"13","author":"Luan","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.celrep.2019.07.016","article-title":"Modeling Human Cancer-induced Cachexia","volume":"28","author":"Talbert","year":"2019","journal-title":"Cell Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1126\/science.134.3495.2041","article-title":"Toxohormone-like factor from microorganisms with impaired respiration","volume":"134","author":"Callao","year":"1961","journal-title":"Science"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: The metabolic requirements of cell proliferation","volume":"324","author":"Cantley","year":"2009","journal-title":"Science"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cmet.2011.07.014","article-title":"Metabolic flux and the regulation of mammalian cell growth","volume":"14","author":"Locasale","year":"2011","journal-title":"Cell Metab."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Liberti, M.V., and Locasale, J.W. (2016). The Warburg Effect: How Does it Benefit Cancer Cells?. Trends Biochem. Sci., 41, Correction to Trends Biochem. Sci. 2016, 41, 287.","DOI":"10.1016\/j.tibs.2016.01.004"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.celrep.2014.03.057","article-title":"Constant growth rate can be supported by decreasing energy flux and increasing aerobic glycolysis","volume":"7","author":"Slavov","year":"2014","journal-title":"Cell Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2049-3002-2-7","article-title":"Separation of metabolic supply and demand: Aerobic glycolysis as a normal physiological response to fluctuating energetic demands in the membrane","volume":"2","author":"Epstein","year":"2014","journal-title":"Cancer Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrc.2016.114","article-title":"From Krebs to clinic: Glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1111\/j.1872-034X.2008.00435.x","article-title":"Role of branched-chain amino acids in management of cirrhosis and hepatocellular carcinoma","volume":"38","author":"Lam","year":"2008","journal-title":"Hepatol. Res."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Schiliro, C., and Firestein, B.L. (2021). Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation. Cells, 10.","DOI":"10.3390\/cells10051056"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.1038\/s41388-020-01480-z","article-title":"Multifaceted role of branched-chain amino acid metabolism in cancer","volume":"39","author":"Peng","year":"2020","journal-title":"Oncogene"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/MCO.0000000000000430","article-title":"Branched-chain amino acid metabolism in cancer","volume":"21","author":"Ananieva","year":"2018","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Padoan, A., Plebani, M., and Basso, D. (2019). Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20030676"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1182\/blood.V78.6.1476.1476","article-title":"Suppression of chronic myelogenous leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: A novel application for inhibitors of IL-1 activity","volume":"78","author":"Estrov","year":"1991","journal-title":"Blood"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/0002-9378(91)90582-C","article-title":"Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer","volume":"164","author":"Berek","year":"1991","journal-title":"Am. J. Obs. Gynecol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: Mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Cao, Z., Zhao, K., Jose, I., Hoogenraad, N.J., and Osellame, L.D. (2021). Biomarkers for Cancer Cachexia: A Mini Review. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094501"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Gray, S., and Axelsson, B. (2018). The prevalence of deranged C-reactive protein and albumin in patients with incurable cancer approaching death. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0193693"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1074\/jbc.274.2.787","article-title":"Tumor necrosis factor-\u03b1-inducible I\u03baB\u03b1 proteolysis mediated by cytosolic m-calpain: A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-\u03bab activation","volume":"274","author":"Han","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clnu.2011.07.010","article-title":"Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia?","volume":"31","author":"Watt","year":"2012","journal-title":"Clin. Nutr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"43S","DOI":"10.1177\/014860719201600602","article-title":"The role of cytokines in cancer cachexia","volume":"16","author":"Moldawer","year":"1992","journal-title":"J. Parenter. Enter. Nutr."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF00311551","article-title":"Are cytokines possible mediators of cancer cachexia?","volume":"26","author":"Noguchi","year":"1996","journal-title":"Surg. Today"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0899-9007(97)00185-8","article-title":"Cytokines and cachexia","volume":"13","author":"Matthys","year":"1997","journal-title":"Nutrition"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1007\/s00520-013-1878-4","article-title":"Interleukin-6 but not tumour necrosis factor-alpha predicts survival in patients with advanced cancer","volume":"21","author":"Suh","year":"2013","journal-title":"Support. Care Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0039-6060(99)70131-5","article-title":"The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer","volume":"126","author":"Williams","year":"1999","journal-title":"Surgery"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1096\/fj.10-164152","article-title":"Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways","volume":"25","author":"Doyle","year":"2011","journal-title":"FASEB J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1042\/bj2370859","article-title":"The activation of protein degradation in muscle by Ca2+ or muscle injury does not involve a lysosomal mechanism","volume":"237","author":"Furuno","year":"1986","journal-title":"Biochem. J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1152\/japplphysiol.01026.2004","article-title":"IL-6-induced skeletal muscle atrophy","volume":"98","author":"Haddad","year":"2005","journal-title":"J. Appl. Physiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1748-1716.2011.02281.x","article-title":"Skeletal muscle mass recovery from atrophy in IL-6 knockout mice","volume":"202","author":"Washington","year":"2011","journal-title":"Acta Physiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.21037\/atm-20-7269","article-title":"Inhibition of IL-6\/JAK\/STAT3 pathway rescues denervation-induced skeletal muscle atrophy","volume":"8","author":"Huang","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"E1042","DOI":"10.1152\/ajpendo.00410.2012","article-title":"Muscle mTORC1 suppression by IL-6 during cancer cachexia: A role for AMPK","volume":"304","author":"White","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"R201","DOI":"10.1152\/ajpregu.00300.2010","article-title":"Muscle oxidative capacity during IL-6-dependent cancer cachexia","volume":"300","author":"White","year":"2011","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41419-022-04747-3","article-title":"RBMS1 promotes gastric cancer metastasis through autocrine IL-6\/JAK2\/STAT3 signaling","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/mc.23283","article-title":"IL-6 and IL-8, secreted by myofibroblasts in the tumor microenvironment, activate HES1 to expand the cancer stem cell population in early colorectal tumor","volume":"60","author":"Kim","year":"2021","journal-title":"Mol. Carcinog."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"x158","DOI":"10.1093\/annonc\/mdx676.010","article-title":"The role of neuropeptide y in cancer-associated anorexia and its correlation with interleukin-1 beta","volume":"28","author":"Wahid","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s10753-021-01429-8","article-title":"The emerging role of interleukin 1\u03b2 (IL-1\u03b2) in cancer cachexia","volume":"44","author":"Laird","year":"2021","journal-title":"Inflammation"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1073\/pnas.0437939100","article-title":"IL-1 is required for tumor invasiveness and angiogenesis","volume":"100","author":"Voronov","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1096\/fj.03-0329fje","article-title":"IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB\/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis","volume":"17","author":"Jung","year":"2003","journal-title":"FASEB J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1200\/JCO.2005.02.345","article-title":"Prognostic role of interleukin-1\u03b2 gene and interleukin-1 receptor antagonist gene polymorphisms in patients with advanced gastric cancer","volume":"23","author":"Graziano","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Zhang, D., Zheng, H., Zhou, Y., Tang, X., Yu, B., and Li, J. (2007). Association of IL-1beta gene polymorphism with cachexia from locally advanced gastric cancer. BMC Cancer, 7.","DOI":"10.1186\/1471-2407-7-45"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"E852","DOI":"10.1152\/ajpendo.1995.269.5.E852","article-title":"Interleukin-1 beta-induced anorexia and pyrexia in rat: Relationship to hypothalamic neuropeptide Y","volume":"269","author":"McCarthy","year":"1995","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1126\/science.3933111","article-title":"Recombinant human tumor necrosis factor-\u03b1: Effects on proliferation of normal and transformed cells in vitro","volume":"230","author":"Sugarman","year":"1985","journal-title":"Science"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.2741\/3066","article-title":"TNF: A master switch for inflammation to cancer","volume":"13","author":"Sethi","year":"2008","journal-title":"Front. Biosci.-Landmark"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/ars.1999.1.1-97","article-title":"Mitochondria mediate tumor necrosis factor-alpha\/NF-kappaB signaling in skeletal muscle myotubes","volume":"1","author":"Li","year":"1999","journal-title":"Antioxid. Redox Signal."},{"key":"ref_73","first-page":"871","article-title":"Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha","volume":"12","author":"Li","year":"1998","journal-title":"FASEB J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0092-8674(87)90028-6","article-title":"Tumors secreting human TNF\/cachectin induce cachexia in mice","volume":"50","author":"Oliff","year":"1987","journal-title":"Cell"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jcsm.12528","article-title":"Cancer cachexia and its pathophysiology: Links with sarcopenia, anorexia and asthenia","volume":"11","author":"Santos","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.lfs.2016.11.033","article-title":"TNF-\u03b1 and cancer cachexia: Molecular insights and clinical implications","volume":"170","author":"Patel","year":"2017","journal-title":"Life Sci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1002\/ijc.29620","article-title":"Tumor inoculation site affects the development of cancer cachexia and muscle wasting","volume":"137","author":"Matsuyama","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1096\/fj.04-2364com","article-title":"TNF-\u03b1 acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1\/MAFbx in skeletal muscle","volume":"19","author":"Li","year":"2005","journal-title":"FASEB J."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","article-title":"Role of C-Reactive Protein at Sites of Inflammation and Infection","volume":"9","author":"Sproston","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: A new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin. Nutr."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.mco.0000165004.93707.88","article-title":"Systemic inflammation, cachexia and prognosis in patients with cancer","volume":"8","author":"Deans","year":"2005","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jpainsymman.2015.11.025","article-title":"Clinical Implications of C-Reactive Protein as a Prognostic Marker in Advanced Cancer Patients in Palliative Care Settings","volume":"51","author":"Amano","year":"2016","journal-title":"J. Pain. Symptom Manag."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"9503","DOI":"10.1074\/jbc.271.16.9503","article-title":"STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6","volume":"271","author":"Zhang","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_84","first-page":"9","article-title":"C-reactive protein in various disease condition-an overview","volume":"4","author":"Ingle","year":"2011","journal-title":"Asian J. Pharm. Clin. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"595835","DOI":"10.3389\/fimmu.2020.595835","article-title":"C-Reactive Protein and Cancer-Diagnostic and Therapeutic Insights","volume":"11","author":"Hart","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Shrotriya, S., Walsh, D., Nowacki, A.S., Lorton, C., Aktas, A., Hullihen, B., Benanni-Baiti, N., Hauser, K., Ayvaz, S., and Estfan, B. (2018). Serum C-reactive protein is an important and powerful prognostic biomarker in most adult solid tumors. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0202555"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Tavares, P., Gon\u00e7alves, D.M., Santos, L.L., and Ferreira, R. (2021). Revisiting the clinical usefulness of C-reactive protein in the set of cancer cachexia. Porto Biomed. J., 6.","DOI":"10.1097\/j.pbj.0000000000000123"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Shrotriya, S., Walsh, D., Bennani-Baiti, N., Thomas, S., and Lorton, C. (2015). C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0143080"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Hou, Y.C., Wang, C.J., Chao, Y.J., Chen, H.Y., Wang, H.C., Tung, H.L., Lin, J.T., and Shan, Y.S. (2018). Elevated Serum Interleukin-8 Level Correlates with Cancer-Related Cachexia and Sarcopenia: An Indicator for Pancreatic Cancer Outcomes. J. Clin. Med., 7.","DOI":"10.3390\/jcm7120502"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1007\/s00520-016-3553-z","article-title":"A predictive model of inflammatory markers and patient-reported symptoms for cachexia in newly diagnosed pancreatic cancer patients","volume":"25","author":"Fogelman","year":"2017","journal-title":"Support. Care Cancer"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Xiong, X., Liao, X., Qiu, S., Xu, H., Zhang, S., Wang, S., Ai, J., and Yang, L. (2022). CXCL8 in Tumor Biology and Its Implications for Clinical Translation. Front. Mol. Biosci., 9.","DOI":"10.3389\/fmolb.2022.723846"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00424-020-02459-1","article-title":"GDF15, an update of the physiological and pathological roles it plays: A review","volume":"472","author":"Assadi","year":"2020","journal-title":"Pflug. Arch."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3389\/fimmu.2020.00915","article-title":"GDF15 plasma level is inversely associated with level of physical activity and correlates with markers of inflammation and muscle weakness","volume":"11","author":"Conte","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/gerona\/gly153","article-title":"Human Aging and Longevity Are Characterized by High Levels of Mitokines","volume":"74","author":"Conte","year":"2019","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"101569","DOI":"10.1016\/j.arr.2022.101569","article-title":"GDF15, an emerging key player in human aging","volume":"75","author":"Conte","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cmet.2018.07.018","article-title":"The MIC-1\/GDF15-GFRAL Pathway in Energy Homeostasis: Implications for Obesity, Cachexia, and Other Associated Diseases","volume":"28","author":"Tsai","year":"2018","journal-title":"Cell Metab."},{"key":"ref_97","first-page":"543","article-title":"Growth differentiation factor-15\/macrophage inhibitory cytokine-1 induction after kidney and lung injury","volume":"23","author":"Zimmers","year":"2005","journal-title":"Shock"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Suzuki, H., Mitsunaga, S., Ikeda, M., Aoyama, T., Yoshizawa, K., Yoshimatsu, H., Kawai, N., Masuda, M., Miura, T., and Ochiai, A. (2021). Clinical and Tumor Characteristics of Patients with High Serum Levels of Growth Differentiation Factor 15 in Advanced Pancreatic Cancer. Cancers, 13.","DOI":"10.3390\/cancers13194842"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41420-022-00972-z","article-title":"GDF-15 in tumor-derived exosomes promotes muscle atrophy via Bcl-2\/caspase-3 pathway","volume":"8","author":"Zhang","year":"2022","journal-title":"Cell Death Discov."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nut.2019.03.012","article-title":"Mediators of cachexia in cancer patients","volume":"66","author":"Busquets","year":"2019","journal-title":"Nutrition"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41568-020-0251-4","article-title":"Understanding cachexia in the context of metastatic progression","volume":"20","author":"Biswas","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Bai, S., Wang, Z., Wang, M., Li, J., Wei, Y., Xu, R., and Du, J. (2022). Tumor-Derived Exosomes Modulate Primary Site Tumor Metastasis. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.752818"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"860","DOI":"10.18632\/oncotarget.6205","article-title":"GDF15 promotes EMT and metastasis in colorectal cancer","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1158\/1078-0432.CCR-08-3126","article-title":"Macrophage inhibitory cytokine 1: A new prognostic marker in prostate cancer","volume":"15","author":"Brown","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"S245","DOI":"10.1016\/j.annonc.2020.08.155","article-title":"2O growth differentiation factor 15 (GDF-15) neutralization reverses cancer cachexia, restores physical performance and mitigates emesis associated with platinum-based chemotherapy","volume":"31","author":"Wu","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiol. Rev."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"29027","DOI":"10.1074\/jbc.R110.137208","article-title":"Control of translation initiation through integration of signals generated by hormones, nutrients, and exercise","volume":"285","author":"Kimball","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1651-2227.1998.tb01386.x","article-title":"Changes in protein turnover, IGF-I and IGF binding proteins in children with cancer","volume":"87","author":"Cotterill","year":"1998","journal-title":"Acta Paediatr."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1242\/dmm.010389","article-title":"Cellular and molecular mechanisms of muscle atrophy","volume":"6","author":"Bonaldo","year":"2013","journal-title":"Dis. Model. Mech."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10522-013-9432-9","article-title":"Signalling pathways regulating muscle mass in ageing skeletal muscle: The role of the IGF1-Akt-mTOR-FoxO pathway","volume":"14","author":"Sandri","year":"2013","journal-title":"Biogerontology"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/sj.bjc.6602780","article-title":"Expression of the ubiquitin-proteasome pathway and muscle loss in experimental cancer cachexia","volume":"93","author":"Khal","year":"2005","journal-title":"Br. J. Cancer"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s12272-020-01281-8","article-title":"Ubiquitin\u2013proteasome system (UPS) as a target for anticancer treatment","volume":"43","author":"Park","year":"2020","journal-title":"Arch. Pharmacal Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"E996","DOI":"10.1152\/ajpendo.1995.268.5.E996","article-title":"Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma","volume":"268","author":"Baracos","year":"1995","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1038\/onc.2008.297","article-title":"Caspases in apoptosis and beyond","volume":"27","author":"Li","year":"2008","journal-title":"Oncogene"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1097-2765(02)00482-3","article-title":"Mechanisms of caspase activation and inhibition during apoptosis","volume":"9","author":"Shi","year":"2002","journal-title":"Mol. Cell"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1054\/bjoc.2001.1700","article-title":"Cleavage of caspases-1, -3, -6, -8 and -9 substrates by proteases in skeletal muscles from mice undergoing cancer cachexia","volume":"84","author":"Lorite","year":"2001","journal-title":"Br. J. Cancer"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"de Castro, G.S., Simoes, E., Lima, J.D.C.C., Ortiz-Silva, M., Festuccia, W.T., Tokeshi, F., Alc\u00e2ntara, P.S., Otoch, J.P., Coletti, D., and Seelaender, M. (2019). Human Cachexia Induces Changes in Mitochondria, Autophagy and Apoptosis in the Skeletal Muscle. Cancers, 11.","DOI":"10.3390\/cancers11091264"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"11177","DOI":"10.1074\/jbc.M115.641514","article-title":"Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia","volume":"290","author":"Silva","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/(SICI)1097-4598(199910)22:10<1350::AID-MUS3>3.0.CO;2-8","article-title":"Myonuclear domains in muscle adaptation and disease","volume":"22","author":"Allen","year":"1999","journal-title":"Muscle Nerve"},{"key":"ref_120","first-page":"21","article-title":"Morphological and biochemical patterns in skeletal muscle apoptosis","volume":"25","author":"Biagiotti","year":"2010","journal-title":"Histol. Histopathol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1101\/gad.1599207","article-title":"Autophagy: Process and function","volume":"21","author":"Mizushima","year":"2007","journal-title":"Genes. Dev."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Gunadi, J.W., Welliangan, A.S., Soetadji, R.S., Jasaputra, D.K., and Lesmana, R. (2021). The Role of Autophagy Modulated by Exercise in Cancer Cachexia. Life, 11.","DOI":"10.3390\/life11080781"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"7153610","DOI":"10.1155\/2018\/7153610","article-title":"Modulating Metabolism to Improve Cancer-Induced Muscle Wasting","volume":"2018","author":"Penna","year":"2018","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ajpath.2012.12.023","article-title":"Autophagic degradation contributes to muscle wasting in cancer cachexia","volume":"182","author":"Penna","year":"2013","journal-title":"Am. J. Pathol."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Vara-Perez, M., Felipe-Abrio, B., and Agostinis, P. (2019). Mitophagy in cancer: A tale of adaptation. Cells, 8.","DOI":"10.3390\/cells8050493"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.exger.2016.10.003","article-title":"Altered mitochondrial quality control signaling in muscle of old gastric cancer patients with cachexia","volume":"87","author":"Marzetti","year":"2017","journal-title":"Exp. Gerontol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2044-5040-2-14","article-title":"IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the Apc Min\/+ mouse","volume":"2","author":"White","year":"2012","journal-title":"Skelet. Muscle"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1126\/science.283.5407.1482","article-title":"Mitochondrial diseases in man and mouse","volume":"283","author":"Wallace","year":"1999","journal-title":"Science"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1152\/physiolgenomics.00061.2018","article-title":"Transcriptomic analysis of the development of skeletal muscle atrophy in cancer-cachexia in tumor-bearing mice","volume":"50","author":"Blackwell","year":"2018","journal-title":"Physiol. Genom."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Kumari, S., Badana, A.K., Mohan G, M., G, S., and Malla, R. (2018). Reactive Oxygen Species: A Key Constituent in Cancer Survival. Biomark. Insights, 13.","DOI":"10.1177\/1177271918755391"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1042\/bst0311308","article-title":"Cell respiration and formation of reactive oxygen species: Facts and artefacts","volume":"31","author":"Nohl","year":"2003","journal-title":"Biochem. Soc. Trans."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.kint.2017.05.034","article-title":"The hallmarks of mitochondrial dysfunction in chronic kidney disease","volume":"92","author":"Galvan","year":"2017","journal-title":"Kidney Int."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.molcel.2012.09.025","article-title":"Physiological roles of mitochondrial reactive oxygen species","volume":"48","author":"Sena","year":"2012","journal-title":"Mol. Cell"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0891-5849(02)00780-3","article-title":"Oxidatively modified proteins in aging and disease","volume":"32","author":"Beal","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.1073\/pnas.85.17.6465","article-title":"Normal oxidative damage to mitochondrial and nuclear DNA is extensive","volume":"85","author":"Richter","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","article-title":"Oxidative stress in cancer","volume":"38","author":"Hayes","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Dodson, M., Castro-Portuguez, R., and Zhang, D.D. (2019). NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol., 23.","DOI":"10.1016\/j.redox.2019.101107"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","article-title":"Activation of apoptosis signalling pathways by reactive oxygen species","volume":"1863","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.biochi.2005.10.004","article-title":"Metabolic profiling by 13C-NMR spectroscopy: [1,2-13C2]glucose reveals a heterogeneous metabolism in human leukemia T cells","volume":"88","author":"Miccheli","year":"2006","journal-title":"Biochimie"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Lee, M., and Yoon, J.-H. (2015). Metabolic interplay between glycolysis and mitochondrial oxidation: The reverse Warburg effect and its therapeutic implication. World J. Biol. Chem., 6.","DOI":"10.4331\/wjbc.v6.i3.148"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.bbrc.2003.11.136","article-title":"Cancer metabolism: Facts, fantasy, and fiction","volume":"313","author":"Zu","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bbabio.2006.11.018","article-title":"Cell surface oxygen consumption: A major contributor to cellular oxygen consumption in glycolytic cancer cell lines","volume":"1767","author":"Herst","year":"2007","journal-title":"Biochim. Biophys. Acta-Bioenerg."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00204-015-1520-y","article-title":"Interactions between mitochondrial reactive oxygen species and cellular glucose metabolism","volume":"89","author":"Willems","year":"2015","journal-title":"Arch. Toxicol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.bbrc.2015.10.022","article-title":"Identification of a novel compound that inhibits both mitochondria-mediated necrosis and apoptosis","volume":"467","author":"Arakawa","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ceb.2009.12.003","article-title":"Necroptosis as an alternative form of programmed cell death","volume":"22","author":"Christofferson","year":"2010","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_146","first-page":"5789","article-title":"Relationship between Metabolic Reprogramming and Mitochondrial Activity in Cancer Cells. Understanding the Anticancer Effect of Metformin and Its Clinical Implications","volume":"35","author":"Cazzaniga","year":"2015","journal-title":"Anticancer. Res."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2049-3002-2-10","article-title":"Defects in mitochondrial metabolism and cancer","volume":"2","author":"Gaude","year":"2014","journal-title":"Cancer Metab."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cell.2015.12.042","article-title":"Phosphoinositide 3-Kinase Regulates Glycolysis through Mobilization of Aldolase from the Actin Cytoskeleton","volume":"164","author":"Hu","year":"2016","journal-title":"Cell"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","article-title":"The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism","volume":"20","author":"Hoxhaj","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cpt.2022.09.001","article-title":"PI3K\/AKT\/mTOR pathway, hypoxia, and glucose metabolism: Potential targets to overcome radioresistance in small cell lung cancer","volume":"1","author":"Deng","year":"2023","journal-title":"Cancer Pathog. Ther."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1113\/JP280572","article-title":"Regulation of glycolysis by the hypoxia-inducible factor (HIF): Implications for cellular physiology","volume":"599","author":"Kierans","year":"2021","journal-title":"J. Physiol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/1566524018666181109121849","article-title":"Role of HIF-1 in cancer progression: Novel insights. A review","volume":"18","author":"Pezzuto","year":"2018","journal-title":"Curr. Mol. Med."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"114","DOI":"10.15698\/cst2020.06.221","article-title":"Mitochondria in cancer","volume":"4","author":"Grasso","year":"2020","journal-title":"Cell Stress."},{"key":"ref_154","first-page":"198","article-title":"The metabolic modulator PGC-1\u03b1 in cancer","volume":"9","author":"Bost","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1152\/japplphysiol.01264.2001","article-title":"Invited Review: Autocrine\/paracrine IGF-I and skeletal muscle adaptation","volume":"93","author":"Adams","year":"2002","journal-title":"J. Appl. Physiol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.cellbio.20.012103.135836","article-title":"Regulation of muscle mass by myostatin","volume":"20","author":"Lee","year":"2004","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators","volume":"127","author":"Drori","year":"2006","journal-title":"Cell"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.cell.2012.10.050","article-title":"A PGC-1\u03b1 isoform induced by resistance training regulates skeletal muscle hypertrophy","volume":"151","author":"Ruas","year":"2012","journal-title":"Cell"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"E208","DOI":"10.1152\/ajpendo.00051.2003","article-title":"Effects of acute bouts of running and swimming exercise on PGC-1alpha protein expression in rat epitrochlearis and soleus muscle","volume":"286","author":"Terada","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1113\/jphysiol.2002.034850","article-title":"Exercise induces transient transcriptional activation of the PGC-1alpha gene in human skeletal muscle","volume":"546","author":"Pilegaard","year":"2003","journal-title":"J. Physiol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"C217","DOI":"10.1152\/ajpcell.00070.2009","article-title":"The role of PGC-1\u03b1 on mitochondrial function and apoptotic susceptibility in muscle","volume":"297","author":"Adhihetty","year":"2009","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"43202","DOI":"10.18632\/oncotarget.6439","article-title":"Combination of exercise training and erythropoietin prevents cancer-induced muscle alterations","volume":"6","author":"Pin","year":"2015","journal-title":"Oncotarget"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"40235","DOI":"10.1074\/jbc.M004356200","article-title":"Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation","volume":"275","author":"Thomas","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"C1248","DOI":"10.1152\/ajpcell.00104.2009","article-title":"Smad2 and 3 transcription factors control muscle mass in adulthood","volume":"296","author":"Sartori","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"C1258","DOI":"10.1152\/ajpcell.00105.2009","article-title":"Myostatin reduces Akt\/TORC1\/p70S6K signaling, inhibiting myoblast differentiation and myotube size","volume":"296","author":"Trendelenburg","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1210\/me.2011-1124","article-title":"Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting","volume":"25","author":"Lokireddy","year":"2011","journal-title":"Mol. Endocrinol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cmet.2011.12.001","article-title":"Srf-dependent paracrine signals produced by myofibers control satellite cell-mediated skeletal muscle hypertrophy","volume":"15","author":"Guerci","year":"2012","journal-title":"Cell Metab."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1073\/pnas.0408729102","article-title":"Muscle regeneration in the prolonged absence of myostatin","volume":"102","author":"Wagner","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"151","DOI":"10.11005\/jbm.2020.27.3.151","article-title":"Myostatin Inhibitors: Panacea or Predicament for Musculoskeletal Disorders?","volume":"27","author":"Suh","year":"2020","journal-title":"J. Bone Metab."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1073\/pnas.0709144105","article-title":"Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors","volume":"105","author":"Haidet","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1113\/jphysiol.2011.226001","article-title":"Myostatin inhibition induces muscle fibre hypertrophy prior to satellite cell activation","volume":"590","author":"Wang","year":"2012","journal-title":"J. Physiol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/gerona\/glp068","article-title":"Myostatin inhibition enhances the effects of exercise on performance and metabolic outcomes in aged mice","volume":"64","author":"LeBrasseur","year":"2009","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.bbrc.2009.12.123","article-title":"Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia","volume":"391","author":"Aydogdu","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2362.2008.01970.x","article-title":"Muscle myostatin signalling is enhanced in experimental cancer cachexia","volume":"38","author":"Costelli","year":"2008","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1111\/cas.15491","article-title":"Combination therapy with anamorelin and a myostatin inhibitor is advantageous for cancer cachexia in a mouse model","volume":"113","author":"Hanada","year":"2022","journal-title":"Cancer Sci."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/jcsm.12310","article-title":"Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses","volume":"9","author":"Nissinen","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"C195","DOI":"10.1152\/ajpcell.00012.2011","article-title":"Human myostatin negatively regulates human myoblast growth and differentiation","volume":"301","author":"McFarlane","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"348ra398","DOI":"10.1126\/scitranslmed.aac4976","article-title":"Smad7 gene delivery prevents muscle wasting associated with cancer cachexia in mice","volume":"8","author":"Winbanks","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1","DOI":"10.17987\/jcsm-cr.v2i1.37","article-title":"Myostatin inhibitors as pharmacological treatment for muscle wasting and muscular dystrophy","volume":"2","author":"Saitoh","year":"2017","journal-title":"JCSM Clin. Rep."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fphys.2019.00042","article-title":"Role of Myokines in Regulating Skeletal Muscle Mass and Function","volume":"10","author":"Lee","year":"2019","journal-title":"Front. Physiol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1016\/j.febslet.2008.10.021","article-title":"FGF21 is an Akt-regulated myokine","volume":"582","author":"Izumiya","year":"2008","journal-title":"FEBS Lett."},{"key":"ref_184","first-page":"32","article-title":"Possible therapeutics: Myokines","volume":"7","author":"Akbulut","year":"2022","journal-title":"Demiroglu Sci. Univ. Florence Nightingale J. Transplant."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/ehf2.12502","article-title":"Fibroblast growth factor 21 in patients with cardiac cachexia: A possible role of chronic inflammation","volume":"6","author":"Christensen","year":"2019","journal-title":"ESC Heart Fail."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.nut.2018.11.004","article-title":"Higher serum levels of fibroblast growth factor 21 in old patients with cachexia","volume":"63\u201364","author":"Franz","year":"2019","journal-title":"Nutrition"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/jcsm.12500","article-title":"The authors reply: Letter on: \u201cFibroblast growth factor 21 controls mitophagy and muscle mass\u201d by Oost et al","volume":"11","author":"Oost","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/japplphysiol.00080.2007","article-title":"Role of myokines in exercise and metabolism","volume":"103","author":"Pedersen","year":"2007","journal-title":"J. Appl. Physiol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1242\/jeb.048074","article-title":"Muscles and their myokines","volume":"214","author":"Pedersen","year":"2011","journal-title":"J. Exp. Biol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1507\/endocrj.K10E-400","article-title":"Upregulation of circulating IL-15 by treadmill running in healthy individuals: Is IL-15 an endocrine mediator of the beneficial effects of endurance exercise?","volume":"58","author":"Tamura","year":"2011","journal-title":"Endocr. J."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1586\/1744666X.2014.973856","article-title":"Interleukin-15 in the treatment of cancer","volume":"10","author":"Waldmann","year":"2014","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1182\/blood-2006-02-002774","article-title":"Regulatory T cells in cancer","volume":"108","author":"Beyer","year":"2006","journal-title":"Blood"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/cmi.2017.35","article-title":"B cell regulation in cancer and anti-tumor immunity","volume":"14","author":"Sarvaria","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1226::AID-CNCR2>3.0.CO;2-G","article-title":"Natural killer cells and cancer","volume":"77","author":"Brittenden","year":"1996","journal-title":"Cancer"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3892\/or.2012.1928","article-title":"Serum interleukin-15 levels in cancer patients with cachexia","volume":"28","year":"2012","journal-title":"Oncol. Rep."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1054\/bjoc.2000.1299","article-title":"Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats","volume":"83","author":"Costelli","year":"2000","journal-title":"Br. J. Cancer"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cyto.2016.11.005","article-title":"Combined effect of aerobic interval training and selenium nanoparticles on expression of IL-15 and IL-10\/TNF-\u03b1 ratio in skeletal muscle of 4T1 breast cancer mice with cachexia","volume":"90","author":"Shamsi","year":"2017","journal-title":"Cytokine"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.clnu.2009.11.006","article-title":"Loss of adipose tissue and plasma phospholipids: Relationship to survival in advanced cancer patients","volume":"29","author":"Murphy","year":"2010","journal-title":"Clin. Nutr."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/cncr.21013","article-title":"Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care\u2014Correlations with food intake, metabolism, exercise capacity, and hormones","volume":"103","author":"Fouladiun","year":"2005","journal-title":"Cancer: Interdiscip. Int. J. Am. Cancer Soc."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/jcp.26811","article-title":"Adipose tissue dysfunction in cancer cachexia","volume":"234","author":"Daas","year":"2018","journal-title":"J. Cell Physiol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","article-title":"A switch from white to brown fat increases energy expenditure in cancer-associated cachexia","volume":"20","author":"Petruzzelli","year":"2014","journal-title":"Cell Metab."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature13528","article-title":"Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia","volume":"513","author":"Kir","year":"2014","journal-title":"Nature"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.bbalip.2013.02.010","article-title":"Adipose tissue and adipocytes support tumorigenesis and metastasis","volume":"1831","author":"Nieman","year":"2013","journal-title":"Biochim. Biophys. Acta-Mol. Cell Biol. Lipids"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4252\/wjsc.v6.i1.33","article-title":"Distinction of white, beige and brown adipocytes derived from mesenchymal stem cells","volume":"6","author":"Park","year":"2014","journal-title":"World J. Stem Cells"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"100092","DOI":"10.1016\/j.esmoop.2021.100092","article-title":"Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines","volume":"6","author":"Arends","year":"2021","journal-title":"ESMO Open"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1016\/j.jpainsymman.2021.02.034","article-title":"Quality of Life and Symptom Burden Improve in Patients Attending a Multidisciplinary Clinical Service for Cancer Cachexia: A Retrospective Observational Review","volume":"62","author":"Bland","year":"2021","journal-title":"J. Pain. Symptom Manag."},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Nishikawa, H., Goto, M., Fukunishi, S., Asai, A., Nishiguchi, S., and Higuchi, K. (2021). Cancer Cachexia: Its Mechanism and Clinical Significance. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168491"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/nure.12071","article-title":"Long-chain omega-3 fatty acids: Time to establish a dietary reference intake","volume":"71","author":"Flock","year":"2013","journal-title":"Nutr. Rev."},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Fulgoni, V.L., Kris-Etherton, P.M., and Mitmesser, S.H. (2018). Dietary intakes of EPA and DHA omega-3 fatty acids among US childbearing-age and pregnant women: An analysis of NHANES 2001\u20132014. Nutrients, 10.","DOI":"10.3390\/nu10040416"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.18632\/aging.101210","article-title":"Influence of omega-3 fatty acids on skeletal muscle protein metabolism and mitochondrial bioenergetics in older adults","volume":"9","author":"Lalia","year":"2017","journal-title":"Aging"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0899-9007(01)00631-1","article-title":"Cancer cachexia and its treatment with fish-oil-enriched nutritional supplementation","volume":"17","author":"Barber","year":"2001","journal-title":"Nutrition"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1207\/S15327914NC3602_6","article-title":"Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer","volume":"36","author":"Wigmore","year":"2000","journal-title":"Nutr. Cancer"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/(SICI)1097-0142(19980115)82:2<403::AID-CNCR21>3.0.CO;2-1","article-title":"Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: A randomized control trial","volume":"82","author":"Gogos","year":"1998","journal-title":"Cancer"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1212\/01.WNL.0000125178.18862.9D","article-title":"Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy","volume":"62","author":"Tarnopolsky","year":"2004","journal-title":"Neurology"},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Candow, D.G., Forbes, S.C., Chilibeck, P.D., Cornish, S.M., Antonio, J., and Kreider, R.B. (2019). Effectiveness of Creatine Supplementation on Aging Muscle and Bone: Focus on Falls Prevention and Inflammation. J. Clin. Med., 8.","DOI":"10.3390\/jcm8040488"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"222","DOI":"10.12688\/f1000research.5218.1","article-title":"A review of creatine supplementation in age-related diseases: More than a supplement for athletes","volume":"3","author":"Smith","year":"2014","journal-title":"F1000Res"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12970-017-0173-z","article-title":"International Society of Sports Nutrition position stand: Safety and efficacy of creatine supplementation in exercise, sport, and medicine","volume":"14","author":"Kreider","year":"2017","journal-title":"J. Int. Soc. Sports Nutr."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.critrevonc.2018.11.003","article-title":"The potential therapeutic effects of creatine supplementation on body composition and muscle function in cancer","volume":"133","author":"Fairman","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1086662","DOI":"10.3389\/fphar.2022.1086662","article-title":"Creatine modulates cellular energy metabolism and protects against cancer cachexia-associated muscle wasting","volume":"13","author":"Wei","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12603-018-1108-3","article-title":"Low Levels of Branched Chain Amino Acids, Eicosapentaenoic Acid and Micronutrients Are Associated with Low Muscle Mass, Strength and Function in Community-Dwelling Older Adults","volume":"23","author":"Luiking","year":"2019","journal-title":"J. Nutr. Health Aging"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00075197-200101000-00008","article-title":"Regulation of protein synthesis by branched-chain amino acids","volume":"4","author":"Kimball","year":"2001","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"264S","DOI":"10.1093\/jn\/136.1.264S","article-title":"Branched-chain amino acids as fuels and anabolic signals in human muscle","volume":"136","author":"Rennie","year":"2006","journal-title":"J. Nutr."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000319998","article-title":"mTOR signaling as a target of amino acid treatment of the age-related sarcopenia","volume":"37","author":"Nisoli","year":"2010","journal-title":"Interdiscip. Top. Gerontol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s12276-020-0375-3","article-title":"Amino acids in cancer","volume":"52","author":"Lieu","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/1097-0142(19860701)58:1<147::AID-CNCR2820580126>3.0.CO;2-I","article-title":"Improved protein kinetics and albumin synthesis by branched chain amino acid-enriched total parenteral nutrition in cancer cachexia. A prospective randomized crossover trial","volume":"58","author":"Tayek","year":"1986","journal-title":"Cancer"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/bjs.1800760215","article-title":"Branched chain amino acids as the protein component of parenteral nutrition in cancer cachexia","volume":"76","author":"Hunter","year":"1989","journal-title":"Br. J. Surg."},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Ventrucci, G., Mello, M.A., and Gomes-Marcondes, M.C. (2007). Leucine-rich diet alters the eukaryotic translation initiation factors expression in skeletal muscle of tumour-bearing rats. BMC Cancer, 7.","DOI":"10.1186\/1471-2407-7-42"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1042\/BJ20070651","article-title":"Effect of branched-chain amino acids on muscle atrophy in cancer cachexia","volume":"407","author":"Eley","year":"2007","journal-title":"Biochem. J."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0955-2863(97)00048-X","article-title":"Nutritional role of the leucine metabolite \u03b2-hydroxy \u03b2-methylbutyrate (HMB)","volume":"8","author":"Nissen","year":"1997","journal-title":"J. Nutr. Biochem."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.fct.2008.11.021","article-title":"Effect of beta-hydroxy-beta-methylbutyrate (HMB) on protein metabolism in whole body and in selected tissues","volume":"47","author":"Holecek","year":"2009","journal-title":"Food Chem. Toxicol."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.clnu.2017.09.024","article-title":"Impact of the calcium form of \u03b2-hydroxy-\u03b2-methylbutyrate upon human skeletal muscle protein metabolism","volume":"37","author":"Wilkinson","year":"2018","journal-title":"Clin. Nutr."},{"key":"ref_232","doi-asserted-by":"crossref","unstructured":"Courel-Ib\u00e1\u00f1ez, J., Vetrovsky, T., Dadova, K., Pallar\u00e9s, J.G., and Steffl, M. (2019). Health benefits of \u03b2-Hydroxy-\u03b2-Methylbutyrate (HMB) supplementation in addition to physical exercise in older adults: A systematic review with meta-analysis. Nutrients, 11.","DOI":"10.3390\/nu11092082"},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Maykish, A., and Sikalidis, A.K. (2020). Utilization of hydroxyl-methyl butyrate, leucine, glutamine and arginine supplementation in nutritional management of sarcopenia\u2014Implications and clinical considerations for Type 2 diabetes mellitus risk modulation. J. Pers. Med., 10.","DOI":"10.3390\/jpm10010019"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nutres.2018.02.006","article-title":"A role for nutritional intervention in addressing the aging neuromuscular junction","volume":"53","author":"Kougias","year":"2018","journal-title":"Nutr. Res."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0002-9610(02)00823-1","article-title":"Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine","volume":"183","author":"May","year":"2002","journal-title":"Am. J. Surg."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.juro.2018.10.010","article-title":"Perioperative Oral Nutrition Supplementation Reduces Prevalence of Sarcopenia following Radical Cystectomy: Results of a Prospective Randomized Controlled Trial","volume":"201","author":"Ritch","year":"2019","journal-title":"J. Urol."},{"key":"ref_237","first-page":"e2020061","article-title":"The effects of protein support with various content on nutrition status and clinical outcomes in elderly malnourished cancer patients","volume":"22","author":"Parlak","year":"2020","journal-title":"Prog. Nutr."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2049-3002-2-18","article-title":"Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia","volume":"2","author":"Shukla","year":"2014","journal-title":"Cancer Metab."},{"key":"ref_239","doi-asserted-by":"crossref","unstructured":"Maurer, G.D., Brucker, D.P., B\u00e4hr, O., Harter, P.N., Hattingen, E., Walenta, S., Mueller-Klieser, W., Steinbach, J.P., and Rieger, J. (2011). Differential utilization of ketone bodies by neurons and glioma cell lines: A rationale for ketogenic diet as experimental glioma therapy. BMC Cancer, 11.","DOI":"10.1186\/1471-2407-11-315"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/ijc.28809","article-title":"Ketone supplementation decreases tumor cell viability and prolongs survival of mice with metastatic cancer","volume":"135","author":"Poff","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0074-7696(08)62748-5","article-title":"Physiological and pathological changes in mitochondrial morphology","volume":"Volume 9","author":"Rouiller","year":"1960","journal-title":"International Review of Cytology"},{"key":"ref_242","doi-asserted-by":"crossref","unstructured":"Nakamura, K., Tonouchi, H., Sasayama, A., and Ashida, K. (2018). A Ketogenic Formula Prevents Tumor Progression and Cancer Cachexia by Attenuating Systemic Inflammation in Colon 26 Tumor-Bearing Mice. Nutrients, 10.","DOI":"10.3390\/nu10020206"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1743-7075-8-54","article-title":"Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: A pilot trial","volume":"8","author":"Schmidt","year":"2011","journal-title":"Nutr. Metab."},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"Poff, A.M., Ari, C., Seyfried, T.N., and D\u2019Agostino, D.P. (2013). The ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0065522"},{"key":"ref_245","doi-asserted-by":"crossref","unstructured":"Poff, A.M., Ward, N., Seyfried, T.N., Arnold, P., and D\u2019Agostino, D.P. (2015). Non-Toxic Metabolic Management of Metastatic Cancer in VM Mice: Novel Combination of Ketogenic Diet, Ketone Supplementation, and Hyperbaric Oxygen Therapy. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0127407"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.nut.2012.05.001","article-title":"Targeting insulin inhibition as a metabolic therapy in advanced cancer: A pilot safety and feasibility dietary trial in 10 patients","volume":"28","author":"Fine","year":"2012","journal-title":"Nutrition"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"789174","DOI":"10.1155\/2012\/789174","article-title":"Insulin resistance and cancer risk: An overview of the pathogenetic mechanisms","volume":"2012","author":"Arcidiacono","year":"2012","journal-title":"Exp. Diabetes Res."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1158\/0008-5472.CAN-03-2904","article-title":"Akt stimulates aerobic glycolysis in cancer cells","volume":"64","author":"Elstrom","year":"2004","journal-title":"Cancer Res."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/annonc\/mdt549","article-title":"The prognosis of incurable cachectic cancer patients on home parenteral nutrition: A multi-centre observational study with prospective follow-up of 414 patients","volume":"25","author":"Bozzetti","year":"2014","journal-title":"Ann. Oncol."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"127","DOI":"10.15430\/JCP.2017.22.3.127","article-title":"Rationale, Feasibility and Acceptability of Ketogenic Diet for Cancer Treatment","volume":"22","author":"Chung","year":"2017","journal-title":"J. Cancer Prev."},{"key":"ref_251","doi-asserted-by":"crossref","unstructured":"Bojkov\u00e1, B., Winklewski, P.J., and Wszedybyl-Winklewska, M. (2020). Dietary fat and cancer\u2014Which is good, which is bad, and the body of evidence. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21114114"},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.3389\/fimmu.2018.02649","article-title":"Inflammatory links between high fat diets and diseases","volume":"9","author":"Duan","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/JLB.4HI0517-210R","article-title":"Frontline Science: High fat diet and leptin promote tumor progression by inducing myeloid-derived suppressor cells","volume":"103","author":"Clements","year":"2018","journal-title":"J. Leukoc. Biol."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.molmed.2013.02.006","article-title":"The role of triglyceride lipases in cancer associated cachexia","volume":"19","author":"Das","year":"2013","journal-title":"Trends Mol. Med."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.1158\/0008-5472.CAN-10-3973","article-title":"A low carbohydrate, high protein diet slows tumor growth and prevents cancer initiation","volume":"71","author":"Ho","year":"2011","journal-title":"Cancer Res."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/bjc.1987.149","article-title":"Reduction of weight loss and tumour size in a cachexia model by a high fat diet","volume":"56","author":"Tisdale","year":"1987","journal-title":"Br. J. Cancer"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-15-0916","article-title":"A Supplemented High-Fat Low-Carbohydrate Diet for the Treatment of Glioblastoma","volume":"22","author":"Martuscello","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_258","doi-asserted-by":"crossref","unstructured":"Li, R.J., Liu, Y., Liu, H.Q., and Li, J. (2020). Ketogenic diets and protective mechanisms in epilepsy, metabolic disorders, cancer, neuronal loss, and muscle and nerve degeneration. J. Food Biochem., 44.","DOI":"10.1111\/jfbc.13140"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2478\/hukin-2019-0071","article-title":"Ketogenic Diet and Skeletal Muscle Hypertrophy: A Frenemy Relationship?","volume":"68","author":"Paoli","year":"2019","journal-title":"J. Hum. Kinet."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.clnu.2021.02.005","article-title":"ESPEN practical guideline: Clinical Nutrition in cancer","volume":"40","author":"Muscaritoli","year":"2021","journal-title":"Clin. Nutr."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1358\/dot.2022.58.3.3381585","article-title":"Anamorelin for cancer cachexia","volume":"58","author":"Nishie","year":"2022","journal-title":"Drugs Today"},{"key":"ref_262","unstructured":"Hain, B.A., Narasimhan, A., Ballinger, T.J., Guise, T.A., and Waning, D.L. (2020). Encyclopedia of Bone Biology, Elsevier."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/cncr.31128","article-title":"Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04)","volume":"124","author":"Katakami","year":"2018","journal-title":"Cancer"},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1002\/cncr.32406","article-title":"A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia","volume":"125","author":"Hamauchi","year":"2019","journal-title":"Cancer"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ghir.2008.12.003","article-title":"Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers","volume":"19","author":"Garcia","year":"2009","journal-title":"Growth Horm. IGF Res."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2217\/fon-2017-0141","article-title":"The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia","volume":"13","author":"Currow","year":"2017","journal-title":"Future Oncol."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s13539-014-0159-5","article-title":"Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: Preclinical profile","volume":"5","author":"Pietra","year":"2014","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): Results from two randomised, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/cncr.34154","article-title":"A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in patients with cancer cachexia and low body mass index","volume":"128","author":"Naito","year":"2022","journal-title":"Cancer"},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.ymthe.2023.06.020","article-title":"Development of a peptide drug restoring AMPK and adipose tissue functionality in cancer cachexia","volume":"31","author":"Ji","year":"2023","journal-title":"Mol. Ther."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41586-023-06047-y","article-title":"EDA2R\u2013NIK signalling promotes muscle atrophy linked to cancer cachexia","volume":"617","author":"Bilgic","year":"2023","journal-title":"Nature"},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1159\/000346446","article-title":"Clinical studies on the treatment of cancer cachexia with megestrol acetate plus thalidomide","volume":"58","author":"Wen","year":"2012","journal-title":"Chemotherapy"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1200\/JCO.20.00611","article-title":"Management of Cancer Cachexia: ASCO Guideline","volume":"38","author":"Roeland","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/gut.2004.047563","article-title":"Thalidomide in the treatment of cancer cachexia: A randomised placebo controlled trial","volume":"54","author":"Gordon","year":"2005","journal-title":"Gut"},{"key":"ref_275","doi-asserted-by":"crossref","unstructured":"Lim, Y.L., Teoh, S.E., Yaow, C.Y.L., Lin, D.J., Masuda, Y., Han, M.X., Yeo, W.S., and Ng, Q.X. (2022). A Systematic Review and Meta-Analysis of the Clinical Use of Megestrol Acetate for Cancer-Related Anorexia\/Cachexia. J. Clin. Med., 11.","DOI":"10.3390\/jcm11133756"},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1517\/14712598.2011.627850","article-title":"A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer","volume":"11","author":"Bayliss","year":"2011","journal-title":"Expert. Opin. Biol. Ther."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00109-009-0547-z","article-title":"Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia","volume":"88","author":"Mantovani","year":"2010","journal-title":"J. Mol. Med."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1249\/00005768-198506000-00015","article-title":"Endurance exercise modifies cachexia of tumor growth in rats","volume":"17","author":"Deuster","year":"1985","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.1096\/fj.201801862R","article-title":"Moderate exercise in mice improves cancer plus chemotherapy-induced muscle wasting and mitochondrial alterations","volume":"33","author":"Pin","year":"2019","journal-title":"FASEB J."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1139\/y89-135","article-title":"Exercise inhibits progressive growth of the Morris hepatoma 7777 in male and female rats","volume":"67","author":"Baracos","year":"1989","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0277-5379(90)90057-Z","article-title":"Effects of spontaneous physical exercise on experimental cancer anorexia and cachexia","volume":"26","author":"Daneryd","year":"1990","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1249\/MSS.0000000000001916","article-title":"Combined Exercise Training Positively Affects Muscle Wasting in Tumor-Bearing Mice","volume":"51","author":"Ranjbar","year":"2019","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1152\/japplphysiol.01270.2013","article-title":"Cachectic skeletal muscle response to a novel bout of low-frequency stimulation","volume":"116","author":"Puppa","year":"2014","journal-title":"J. Appl. Physiol."},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3389\/fphys.2018.00465","article-title":"Aerobic exercise training attenuates tumor growth and reduces insulin secretion in Walker 256 tumor-bearing rats","volume":"9","author":"Moreira","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_285","first-page":"1107","article-title":"Understanding tumor anabolism and patient catabolism in cancer-associated cachexia","volume":"7","year":"2017","journal-title":"Am. J. Cancer Res."},{"key":"ref_286","first-page":"1409","article-title":"American college of sports medicine roundtable on exercise guidelines for cancer survivors","volume":"42","author":"PANEL","year":"2010","journal-title":"J. ACSM"},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jcsm.12055","article-title":"Exercise for cancer cachexia in adults: Executive summary of a Cochrane Collaboration systematic review","volume":"6","author":"Grande","year":"2015","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/cbf.1594","article-title":"Chronic exercise decreases cytokine production in healthy rat skeletal muscle","volume":"27","author":"Lira","year":"2009","journal-title":"Cell Biochem. Funct."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.7150\/jca.17162","article-title":"Positive Prehabilitative Effect of Intense Treadmill Exercise for Ameliorating Cancer Cachexia Symptoms in a Mouse Model","volume":"7","author":"Jee","year":"2016","journal-title":"J. Cancer"},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/jcsm.12944","article-title":"Exercise reduces intramuscular stress and counteracts muscle weakness in mice with breast cancer","volume":"13","author":"Mader","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_291","doi-asserted-by":"crossref","unstructured":"Re Cecconi, A.D., Forti, M., Chiappa, M., Zhu, Z., Zingman, L.V., Cervo, L., Beltrame, L., Marchini, S., Piccirillo, R., and Musclin, A. (2019). Myokine Induced by Aerobic Exercise, Retards Muscle Atrophy During Cancer Cachexia in Mice. Cancers, 11.","DOI":"10.3390\/cancers11101541"},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.metabol.2016.01.014","article-title":"Aerobic and resistance training dependent skeletal muscle plasticity in the colon-26 murine model of cancer cachexia","volume":"65","author":"Khamoui","year":"2016","journal-title":"Metabolism"},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"26991","DOI":"10.1038\/srep26991","article-title":"Aerobic Exercise and Pharmacological Treatments Counteract Cachexia by Modulating Autophagy in Colon Cancer","volume":"6","author":"Pigna","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_294","doi-asserted-by":"crossref","unstructured":"Morinaga, M., Sako, N., Isobe, M., Lee-Hotta, S., Sugiura, H., and Kametaka, S. (2021). Aerobic Exercise Ameliorates Cancer Cachexia-Induced Muscle Wasting through Adiponectin Signaling. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22063110"},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1249\/MSS.0000000000001991","article-title":"High-Frequency Stimulation on Skeletal Muscle Maintenance in Female Cachectic Mice","volume":"51","author":"Sato","year":"2019","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1152\/japplphysiol.00416.2015","article-title":"Eccentric contraction-induced myofiber growth in tumor-bearing mice","volume":"120","author":"Hardee","year":"2016","journal-title":"J. Appl. Physiol."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"880787","DOI":"10.3389\/fonc.2022.880787","article-title":"Resistance Training Attenuates Activation of STAT3 and Muscle Atrophy in Tumor-Bearing Mice","volume":"12","author":"Testa","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/109980040100200301","article-title":"Resistance exercise training attenuates wasting of the extensor digitorum longus muscle in mice bearing the colon-26 adenocarcinoma","volume":"2","author":"McCarthy","year":"2001","journal-title":"Biol. Res. Nurs."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s00432-022-03927-0","article-title":"Exercise medicine for cancer cachexia: Targeted exercise to counteract mechanisms and treatment side effects","volume":"148","author":"Mavropalias","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1177\/0269215520941912","article-title":"Resistance Training Impact on Mobility, Muscle Strength and Lean Mass in Pancreatic Cancer Cachexia: A Randomized Controlled Trial","volume":"34","author":"Kamel","year":"2020","journal-title":"Clin. Rehabil."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/jcsm.12854","article-title":"Activation of Akt\u2013mTORC1 signalling reverts cancer-dependent muscle wasting","volume":"13","author":"Geremia","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"7852","DOI":"10.1096\/fj.201802430R","article-title":"Preventive effects of low-intensity exercise on cancer cachexia\u2013induced muscle atrophy","volume":"33","author":"Tanaka","year":"2019","journal-title":"FASEB J."},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.3747\/co.24.3619","article-title":"Exercise for people with cancer: A systematic review","volume":"24","author":"Segal","year":"2017","journal-title":"Curr. Oncol."},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/jcsm.12201","article-title":"A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer","volume":"8","author":"Solheim","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1634\/theoncologist.2011-0133","article-title":"Physical exercise for cancer patients with advanced disease: A randomized controlled trial","volume":"16","author":"Oldervoll","year":"2011","journal-title":"Oncologist"},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"397","DOI":"10.21873\/anticanres.15498","article-title":"Moderate Intensity Endurance and Resistance Exercise Attenuates Cachexia in Tumor-bearing Mice","volume":"42","author":"Wood","year":"2022","journal-title":"Anticancer. Res."},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00432-019-02911-5","article-title":"Molecular and cellular adaptations to exercise training in skeletal muscle from cancer patients treated with chemotherapy","volume":"145","author":"Farup","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1055\/s-2005-865848","article-title":"Combined aerobic and resistance training in breast cancer survivors: A randomized, controlled pilot trial","volume":"27","author":"Herrero","year":"2006","journal-title":"Int. J. Sports Med."}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/13\/9\/1024\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:53:41Z","timestamp":1760129621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/13\/9\/1024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,20]]},"references-count":308,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["metabo13091024"],"URL":"https:\/\/doi.org\/10.3390\/metabo13091024","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,20]]}}}